Capecitabine-induced severe hypertriglyceridaemia and diabetes: a case report and review of the literature.
Garg
R
R
Angus
E
E
Fincher
S
S
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001786:Blood Glucose / Q000032:analysis; D000069287:Capecitabine; D003110:Colonic Neoplasms / Q000188:drug therapy; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D011345:Fenofibrate / Q000031:analogs & derivatives / Q000627:therapeutic use; D005472:Fluorouracil / Q000009:adverse effects / Q000031:analogs & derivatives*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D015228:Hypertriglyceridemia / Q000139:chemically induced*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D001786:Blood Glucose; D000069287:Capecitabine; D003841:Deoxycytidine; D011345:Fenofibrate; D005472:Fluorouracil; D006442:Glycated Hemoglobin; D000960:Hypolipidemic Agents; D008055:Lipids; C006012:fenofibric acid